Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

Affiliations

¹ European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
² Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
³ Boehringer Ingelheim Pharma GmbH & Co KG, Clinical Development and Medical Affairs, Ingelheim am Rhein, Germany, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany.
⁴ Cardiovascular Research Foundation and Thomas Jefferson Medical College, New York, NY.
⁵ Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden.

Comment

Eloi Marijon et al. Circulation. 2014.

. 2014 Aug 26;130(9):e85.

doi: 10.1161/CIRCULATIONAHA.114.010275.

¹ European Georges Pompidou Hospital and Paris Descartes University, Paris, France.
² Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, ON, Canada.
³ Boehringer Ingelheim Pharma GmbH & Co KG, Clinical Development and Medical Affairs, Ingelheim am Rhein, Germany, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany.
⁴ Cardiovascular Research Foundation and Thomas Jefferson Medical College, New York, NY.
⁵ Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden.

No abstract available

Comment on

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S; RE-LY Investigators. Marijon E, et al. Circulation. 2013 Nov 12;128(20):2192-201. doi: 10.1161/CIRCULATIONAHA.112.000491. Epub 2013 Sep 9. Circulation. 2013. PMID: 24016454 Clinical Trial.
Letter by Seitz and Beurtheret regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing risk analysis from the randomized evaluation of long-term anticoagulant therapy study".
Seitz J, Beurtheret S. Seitz J, et al. Circulation. 2014 Aug 26;130(9):e84. doi: 10.1161/CIRCULATIONAHA.113.007001. Circulation. 2014. PMID: 25156922 No abstract available.